Dr. Arslan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Bradbury, CA 91010Phone+1 626-256-4673
Summary
- Dr. Shukaib Arslan is a specialized healthcare provider in Hematology with a subspecialty in Hematologic Oncology, based in Duarte, CA. He gained comprehensive experience in his field through his education at different medical institutions, including King Edward Medical University and City of Hope National Medical Center, where he completed a fellowship in Blood & Bone Marrow Transplant. He is currently serving as an Assistant Clinical Professor at City of Hope. Dr. Arslan has contributed a variety of scholarly articles to the medical field, indicating his active participation in research. His work is published in notable journals such as Transplantation and Cellular Therapy, Cureus, and Cancer Medicine.
Education & Training
City of Hope National Medical CenterFellowship, Blood & Bone Marrow Transplant, 2018 - 2019
Ascension Providence/MSUCHMFellowship, Hematology and Medical Oncology, 2015 - 2018
Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 2010 - 2013
King Edward Medical UniversityClass of 2007
Certifications & Licensure
TX State Medical License 2024 - 2026
CA State Medical License 2018 - 2025
MI State Medical License 2012 - 2020
MA State Medical License 2016 - 2016
AR State Medical License 2014 - 2015
Publications & Presentations
PubMed
- Fludarabine melphalan reduced intensity conditioning vs radiation-based myeloablative conditioning in patients undergoing allogeneic transplantation for acute myeloid ...Amanda Blackmon, Michelle Afkhami, Dongyun Yang, Sally Mokhtari, Yazeed Samara
Bone Marrow Transplantation. 2024-12-18 - Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD).Hoda Pourhassan, Tina Nguyen, Dongyun Yang, Salman Otoukesh, Shukaib Arslan
Cancers. 2024-11-22 - Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings.Salman Otoukesh, Dongyun Yang, Sally Mokhtari, Hoda Pourhassan, Vaibhav Agrawal
Bone Marrow Transplantation. 2024-11-01
Abstracts/Posters
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab OzogamicinShukaib Arslan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with BlinatumomabShukaib Arslan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplan...Shukaib Arslan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
